Valeant Pharmaceuticals (VRX) Stock: Climbing on Takeover Rejection!

By |May 27th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is having an incredibly strong day in the market today, and for good reason. News surfaced that the company has made the decision to decline a joint takeover bid. Today, we’ll talk about the details of the bid, how the market reacted to the news, and what […]